A detailed history of Salomon & Ludwin, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Salomon & Ludwin, LLC holds 61 shares of CRL stock, worth $10,236. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61
Holding current value
$10,236
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$145.57 - $178.99 $8,879 - $10,918
61 New
61 $9,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Salomon & Ludwin, LLC Portfolio

Follow Salomon & Ludwin, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salomon & Ludwin, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Salomon & Ludwin, LLC with notifications on news.